Kleiner Perkins Caufield & Byers XIV, LLC 3
Accession 0000899243-18-001928
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 6:05 PM ET
Size
19.8 KB
Accession
0000899243-18-001928
Insider Transaction Report
- (indirect: By KPCB Holdings, Inc., as nominee)
Series A Convertible Preferred Stock
Exercise: $4.71→ Common Stock (1,212,494 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B-1 Convertible Preferred Stock
Exercise: $9.93→ Common Stock (355,429 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C-1 Convertible Preferred Stock
Exercise: $12.35→ Common Stock (326,242 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B Convertible Preferred Stock
Exercise: $6.12→ Common Stock (1,296,248 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series A-1 Convertible Preferred Stock
Exercise: $1.17→ Common Stock (673,173 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C Convertible Preferred Stock
Exercise: $12.35→ Common Stock (403,097 underlying)
- (indirect: By KPCB Holdings, Inc., as nominee)
Series A-1 Convertible Preferred Stock
Exercise: $1.17→ Common Stock (673,173 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B-1 Convertible Preferred Stock
Exercise: $9.93→ Common Stock (355,429 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series A Convertible Preferred Stock
Exercise: $4.71→ Common Stock (1,212,494 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B Convertible Preferred Stock
Exercise: $6.12→ Common Stock (1,296,248 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C Convertible Preferred Stock
Exercise: $12.35→ Common Stock (403,097 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C-1 Convertible Preferred Stock
Exercise: $12.35→ Common Stock (326,242 underlying)
- (indirect: By KPCB Holdings, Inc., as nominee)
Series A-1 Convertible Preferred Stock
Exercise: $1.17→ Common Stock (673,173 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C-1 Convertible Preferred Stock
Exercise: $12.35→ Common Stock (326,242 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B Convertible Preferred Stock
Exercise: $6.12→ Common Stock (1,296,248 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B-1 Convertible Preferred Stock
Exercise: $9.93→ Common Stock (355,429 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series A Convertible Preferred Stock
Exercise: $4.71→ Common Stock (1,212,494 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C Convertible Preferred Stock
Exercise: $12.35→ Common Stock (403,097 underlying)
- (indirect: By KPCB Holdings, Inc., as nominee)
Series A Convertible Preferred Stock
Exercise: $4.71→ Common Stock (1,212,494 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series A-1 Convertible Preferred Stock
Exercise: $1.17→ Common Stock (673,173 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B-1 Convertible Preferred Stock
Exercise: $9.93→ Common Stock (355,429 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C-1 Convertible Preferred Stock
Exercise: $12.35→ Common Stock (326,242 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B Convertible Preferred Stock
Exercise: $6.12→ Common Stock (1,296,248 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C Convertible Preferred Stock
Exercise: $12.35→ Common Stock (403,097 underlying)
- (indirect: By KPCB Holdings, Inc., as nominee)
Series A-1 Convertible Preferred Stock
Exercise: $1.17→ Common Stock (673,173 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B-1 Convertible Preferred Stock
Exercise: $9.93→ Common Stock (355,429 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series A Convertible Preferred Stock
Exercise: $4.71→ Common Stock (1,212,494 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B Convertible Preferred Stock
Exercise: $6.12→ Common Stock (1,296,248 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C Convertible Preferred Stock
Exercise: $12.35→ Common Stock (403,097 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C-1 Convertible Preferred Stock
Exercise: $12.35→ Common Stock (326,242 underlying)
- (indirect: By KPCB Holdings, Inc., as nominee)
Series A-1 Convertible Preferred Stock
Exercise: $1.17→ Common Stock (673,173 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B-1 Convertible Preferred Stock
Exercise: $9.93→ Common Stock (355,429 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series B Convertible Preferred Stock
Exercise: $6.12→ Common Stock (1,296,248 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C-1 Convertible Preferred Stock
Exercise: $12.35→ Common Stock (326,242 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series A Convertible Preferred Stock
Exercise: $4.71→ Common Stock (1,212,494 underlying) - (indirect: By KPCB Holdings, Inc., as nominee)
Series C Convertible Preferred Stock
Exercise: $12.35→ Common Stock (403,097 underlying)
Footnotes (3)
- [F1]Consists of 3,475,576 shares of common stock issuable upon the deemed conversion of shares of the Issuer's preferred stock held by Kleiner Perkins Caufield & Byers XIV, LLC ("KPCB XIV"), 294,029 shares of common stock issuable upon the deemed conversion of shares of the Issuer's preferred stock held by KPCB XIV Founders Fund, LLC ("KPCB XIV FF"), 480,625 shares of common stock issuable upon the deemed conversion of shares of the Issuer's preferred stock held by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 16,453 shares of common stock issuable upon the deemed conversion of shares of the Issuer's preferred stock held by KPCB XVI Founders Fund, LLC ("KPCB XVI FF"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee" for the accounts of such entities.
- [F2](Continued from footnote 1) The managing member of KPCB XIV and KPCB XIV FF is KPCB XIV Associates, LLC ("KPCB XIV Associates"). Brook Byers, L. John Doerr, William Gordon and Theodore Schlein, the managing members of KPCB XIV Associates, and Dr. Beth Seidenberg, a member of KPCB XIV Associates, exercise shared voting and dispositive control over the shares held by KPCB XIV and KPCB XIV FF. The managing member of KPCB XVI and KPCB XVI FF is KPCB XVI Associates, LLC ("KPCB XVI Associates"). L. John Doerr, Eric Feng, Wen Hsieh, Randy Komisar, Dr. Beth Seidenberg and Theodore Schlein, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and KPCB XVI FF.
- [F3]The Series A-1, Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series B-1 Convertible Preferred Stock, the Series C Convertible Preferred Stock and the Series C-1 Convertible Preferred Stock shall automatically convert into Common Stock on a 1-for-1 basis immediately prior to the completion of the Issuer's initial public offering and has no expiration date.
Documents
Issuer
ARMO BioSciences, Inc.
CIK 0001693664
Related Parties
1- filerCIK 0001505781
Filing Metadata
- Form type
- 3
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 6:05 PM ET
- Size
- 19.8 KB